CervoMed Inc (NASDAQ: CRVO) is -74.71% lower on its value in year-to-date trading and has touched a low of $1.90 and a high of $26.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRVO stock was last observed hovering at around $1.95 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $1.93, the stock is -78.09% and -83.01% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.11 million and changing -1.03% at the moment leaves the stock -88.49% off its SMA200. CRVO registered -78.67% loss for a year compared to 6-month loss of -90.23%. The firm has a 50-day simple moving average (SMA 50) of $11.597 and a 200-day simple moving average (SMA200) of $16.8252.
The stock witnessed a -83.69% gain in the last 1 month and extending the period to 3 months gives it a -88.98%, and is -80.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.34% over the week and 17.79% over the month.
CervoMed Inc (CRVO) has around 8 employees, a market worth around $15.92M and $10.07M in sales. Profit margin for the company is -118.68%. Distance from 52-week low is 1.49% and -92.68% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.18%).
The EPS is expected to shrink by -123.78% this year
The shares outstanding are 8.25M, and float is at 5.35M with Short Float at 35.80%.
CervoMed Inc (CRVO) Insider Activity
The most recent transaction is an insider purchase by ELDER WILLIAM ROBERT, the company’s CFO & GC. SEC filings show that ELDER WILLIAM ROBERT bought 1,000 shares of the company’s common stock on Aug 27 ’24 at a price of $18.16 per share for a total of $18160.0. Following the purchase, the insider now owns 1267.0 shares.
